 | | | | Moderna Inc's experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations. | | | | | | Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations. | | | | | | Moderna Inc's experimental COVID-19 vaccine is more stable than expected at temperatures that ordinary refrigerators can provide and can be distributed using existing cold-chain shipping and storage infrastructure. | | | | | | Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19. | | | | | | Inovio Pharmaceuticals Inc said on Monday it had received the U.S. health regulator's clearance to begin a mid-stage study of its COVID-19 vaccine candidate, INO-4800. | | | | | | Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. | | | | | | Europe's health regulator said on Monday it had launched a real-time review of U.S. drugmaker Moderna Inc's experimental COVID-19 vaccine, following similar such reviews of rival vaccines from AstraZeneca and Pfizer . | | | | | | British Prime Minister Boris Johnson's plans for mass COVID-19 testing that might re-open large parts of the economy, known as "Operation Moonshot", are likely to be ineffective and expensive, scientists concerned about the scheme said on Monday. | | | | | | By Clara-Laeila Laudette, Silvio Castellanos and Elena Rodriguez | | | | | | Helplines across Europe have reported higher demand for their services as the coronavirus pandemic adds to the hurdles many women face to access abortion. | | | | | | Despite it being legal in most of Europe, women face difficulties in getting access to abortion in some countries. The problem has been compounded by the coronavirus pandemic which has stretched healthcare services and closed borders. | | | | | |
